Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18529337 | 1.00 | LMNA (0.44) | LMNAL3MBTL1TDP1THRBALDH1A1 | |
| SCHEMBL5599449 | 0.89 | USP2 (0.43) | LMNAL3MBTL1TDP1THRBALDH1A1 | |
| SCHEMBL4429401 | 0.89 | USP2 (0.43) | LMNAL3MBTL1TDP1THRBALDH1A1 | |
| SCHEMBL5158290 | 0.85 | TSHR (0.47) | LMNAL3MBTL1TDP1THRBALDH1A1 | |
| SCHEMBL7736939 | 0.85 | TSHR (0.47) | LMNAL3MBTL1TDP1THRBALDH1A1 | |
| SCHEMBL22289432 | 0.83 | ALDH1A1 (0.43) | LMNAL3MBTL1TDP1ALDH1A1TSHR | |
| SCHEMBL15013779 | 0.83 | ALDH1A1 (0.43) | LMNAL3MBTL1TDP1ALDH1A1TSHR | |
| SCHEMBL3904175 | 0.81 | LMNA (0.56) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| SCHEMBL619757 | 0.81 | LMNA (0.65) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| SCHEMBL3909140 | 0.81 | LMNA (0.65) | LMNAL3MBTL1TDP1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0912546-A1 | IMPROVED RESERVOIR COMPONENTS | AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE (AU) | 1999-05-06 | — | — | EP | claimed |
| WO-1997043274-A1 | IMPROVED RESERVOIR COMPONENTS | AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE (AU) | 1997-11-20 | — | — | WO | claimed |
| WO-2024142849-A1 | WATER-IN-OIL EMULSION COSMETIC COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| CN-117159398-B | Super-fluid compound sun-screening agent and oil-in-water-in-oil triple sun-screening emulsion | 广州嘉瑞新材料有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-11964043-B2 | Method of emulsification using core-corona type microparticles | SHISEIDO COMPANY, LTD. (JP) | 2024-04-23 | — | — | US | disclosed |
| US-11931448-B2 | Water-in-oil type emulsion composition | SHISEIDO COMPANY, LTD. (JP) | 2024-03-19 | — | — | US | disclosed |
| CN-117500478-A | Hair care composition comprising hydroxylated triglyceride oligomers | 宝洁公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117460490-A | Skin external composition containing taurine crystal with useful component | 考司美德制药株式会社 | 2024-01-26 | — | — | CN | disclosed |
| CN-117377454-A | Skin care composition | 考司美德制药株式会社 | 2024-01-09 | — | — | CN | disclosed |
| EP-3520772-B1 | COSMETIC RAW MATERIAL USING CORE-CORONA TYPE MICROPARTICLES AND OIL-IN-WATER TYPE EMULSION COSMETIC | SHISEIDO CO LTD (JP) | 2023-12-20 | — | — | EP | disclosed |
| CN-117159398-A | Super-fluid compound sun-screening agent and oil-in-water-in-oil triple sun-screening emulsion | 广州嘉瑞亚微米生物技术有限公司 | 2023-12-05 | — | — | CN | disclosed |
| US-20040197361-A1 | External preparation for the skin | SHISEIDO COMPANY, LTD. (JP) | 2004-10-07 | — | — | US | disclosed |
| EP-1430905-A1 | EXTERNAL PREPARATION FOR THE SKIN | SHISEIDO COMPANY LIMITED (JP) | 2004-06-23 | — | — | EP | disclosed |
| US-6607736-B2 | Endermic liniment comprising diethoxy ethyl succinate and humectant | SHISEIDO COMPANY, LTD. (JP) | 2003-08-19 | — | — | US | disclosed |
| US-20030091603-A1 | Skin preparations for external use | SHISEIDO COMPANY, LTD. (JP) | 2003-05-15 | — | — | US | disclosed |
| EP-1230026-A1 | ION EXCHANGE RESINS AND METHODS OF MAKING THE SAME | BASF AKTIENGESELLSCHAFT (DE) | 2002-08-14 | — | — | EP | disclosed |
| US-6417009-B1 | COUPLING LIPID | AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY INSTITUTE (AU) | 2002-07-09 | — | — | US | disclosed |
| EP-1153602-A1 | SKIN PREPARATIONS FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 2001-11-14 | — | — | EP | disclosed |
| WO-2001030495-A1 | ION EXCHANGE RESINS AND METHODS OF MAKING THE SAME | BASF AKTIENGESELLSCHAFT (DE) | 2001-05-03 | — | — | WO | disclosed |
| US-4351738-A | ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER | TEIJIN LIMITED (JP) | 1982-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030091603-A1 | Skin preparations for external use | CUTA, POLR1C, ACMSD | LMNA 524/4885L3MBTL1 490/4885TDP1 263/4885 |
| US-11964043-B2 | Method of emulsification using core-corona type microparticles | LIPA, CORO1A, CLTA | LMNA 360/4885L3MBTL1 4505/4885TDP1 2854/4885 |
| US-20040197361-A1 | External preparation for the skin | CUTA, DDOST, DSG1 | LMNA 2593/4885L3MBTL1 4235/4885TDP1 2076/4885 |
| US-11931448-B2 | Water-in-oil type emulsion composition | FAM83A, LIPA, CUTA | LMNA 154/4885L3MBTL1 1865/4885TDP1 1806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.